RxDoctor Payments Data

Haylee Mague, PA

Physician Assistant · Warren, PANPI 1538777503

Payments from drug & device makers

$860in general payments, 2019–2025

Across 35 payments — averaging $24.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$274
  • Boston Scientific$164
  • Exact Sciences$125
  • Bayer$76
  • Pfizer$59
  • Lilly USA, LLC$27
  • plus $135 from 8 others

What the payments were for

  • Food & beverage$860100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$860 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$57,610
Medicare patients
276
Services billed
702

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$79,286
XareltoRivaroxaban53$61,704
OzempicSemaglutide48$61,499
JanuviaSitagliptin Phosphate25$30,233
TrulicityDulaglutide20$28,188
Breo ElliptaFluticasone/Vilanterol52$27,629
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$25,160
JardianceEmpagliflozin14$21,423
TradjentaLinagliptin18$17,773
MounjaroTirzepatide13$13,098
Soliqua 100-33Insulin Glargine/Lixisenatide13$11,392
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,169
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$10,593
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$7,267
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$5,314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$59$79,28669 claims
Novo NordiskOzempic$15$61,49948 claims
Lilly USA, LLCTrulicity, Mounjaro$27$41,28633 claims
MerckJanuvia$19$30,23325 claims
AstraZenecaBreztri Aerosphere$274$11,16917 claims
AbbVieSynthroid$17$3,22472 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Warren

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →